234 related articles for article (PubMed ID: 23888367)
1. 2013 update: Hopkins lupus cohort.
Fangtham M; Petri M
Curr Rheumatol Rep; 2013 Sep; 15(9):360. PubMed ID: 23888367
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal Evaluation of Lipoprotein Variables in Systemic Lupus Erythematosus Reveals Adverse Changes with Disease Activity and Prednisone and More Favorable Profiles with Hydroxychloroquine Therapy.
Durcan L; Winegar DA; Connelly MA; Otvos JD; Magder LS; Petri M
J Rheumatol; 2016 Apr; 43(4):745-50. PubMed ID: 26834214
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.
Groot N; Shaikhani D; Teng YKO; de Leeuw K; Bijl M; Dolhain RJEM; Zirkzee E; Fritsch-Stork R; Bultink IEM; Kamphuis S
Arthritis Rheumatol; 2019 Feb; 71(2):290-301. PubMed ID: 30152151
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
Ruiz-Irastorza G; Danza A; Khamashta M
Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
[TBL] [Abstract][Full Text] [Related]
5. "Protenuria in SLE: Is it always lupus?".
Celia AI; Priori R; Cerbelli B; Diomedi-Camassei F; Leuzzi V; Scrivo R; Alessandri C; d'Amati G; Conti F
Lupus; 2021 Apr; 30(4):664-668. PubMed ID: 33413001
[TBL] [Abstract][Full Text] [Related]
6. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
Fanouriakis A; Kostopoulou M; Cheema K; Anders HJ; Aringer M; Bajema I; Boletis J; Frangou E; Houssiau FA; Hollis J; Karras A; Marchiori F; Marks SD; Moroni G; Mosca M; Parodis I; Praga M; Schneider M; Smolen JS; Tesar V; Trachana M; van Vollenhoven RF; Voskuyl AE; Teng YKO; van Leew B; Bertsias G; Jayne D; Boumpas DT
Ann Rheum Dis; 2020 Jun; 79(6):713-723. PubMed ID: 32220834
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoids and antimalarials in systemic lupus erythematosus: an update and future directions.
Ugarte A; Danza A; Ruiz-Irastorza G
Curr Opin Rheumatol; 2018 Sep; 30(5):482-489. PubMed ID: 29870497
[TBL] [Abstract][Full Text] [Related]
8. Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus.
Tsang-A-Sjoe MW; Bultink IE; Heslinga M; Voskuyl AE
Rheumatology (Oxford); 2017 Jan; 56(1):121-128. PubMed ID: 27803306
[TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine-induced phospholipidosis in a case of SLE: the wolf in zebra clothing.
Khubchandani SR; Bichle LS
Ultrastruct Pathol; 2013 Apr; 37(2):146-50. PubMed ID: 23573895
[TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine Serum Concentrations and Flares of Systemic Lupus Erythematosus: A Longitudinal Cohort Analysis.
Mok CC; Penn HJ; Chan KL; Tse SM; Langman LJ; Jannetto PJ
Arthritis Care Res (Hoboken); 2016 Sep; 68(9):1295-302. PubMed ID: 26749299
[TBL] [Abstract][Full Text] [Related]
11. An integrated extrapolation of long-term outcomes in systemic lupus erythematosus: analysis and simulation of the Hopkins lupus cohort.
Watson P; Brennan A; Birch H; Fang H; Petri M
Rheumatology (Oxford); 2015 Apr; 54(4):623-32. PubMed ID: 25234659
[TBL] [Abstract][Full Text] [Related]
12. Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis.
Feldman CH; Hiraki LT; Winkelmayer WC; Marty FM; Franklin JM; Kim SC; Costenbader KH
Arthritis Rheumatol; 2015 Jun; 67(6):1577-85. PubMed ID: 25772621
[TBL] [Abstract][Full Text] [Related]
13. [Transverse myelopathy and systemic lupus erythematosus. Report of a case and review of the literature].
de Macedo DD; de Mattos JP; Borges TM
Arq Neuropsiquiatr; 1979 Mar; 37(1):76-84. PubMed ID: 464863
[TBL] [Abstract][Full Text] [Related]
14. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
He F; Luo Q; Lei M; Fan L; Shao X; Hu K; Qin S; Yu N; Cao J; Yang L
Clin Rheumatol; 2020 Sep; 39(9):2803-2810. PubMed ID: 32725351
[TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis.
Petri M
Lupus; 1996 Jun; 5 Suppl 1():S16-22. PubMed ID: 8803905
[TBL] [Abstract][Full Text] [Related]
16. Practice Variations in the Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus in Canada.
Keeling SO; Bissonauth A; Bernatsky S; Vandermeer B; Fortin PR; Gladman DD; Peschken C; Urowitz MB
J Rheumatol; 2018 Oct; 45(10):1440-1447. PubMed ID: 30068762
[TBL] [Abstract][Full Text] [Related]
17. Hydroxychloroquine in systemic lupus erythematosus (SLE).
Ponticelli C; Moroni G
Expert Opin Drug Saf; 2017 Mar; 16(3):411-419. PubMed ID: 27927040
[TBL] [Abstract][Full Text] [Related]
18. [Systemic lupus erythematosus in children and adolescents].
Sallmann S; Fiebig B; Hedrich CM; Heubner G; Gahr M
Z Rheumatol; 2006 Nov; 65(7):576-8, 580-2, 584-5. PubMed ID: 17072573
[TBL] [Abstract][Full Text] [Related]
19. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus.
McLaurin EY; Holliday SL; Williams P; Brey RL
Neurology; 2005 Jan; 64(2):297-303. PubMed ID: 15668428
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus.
Vázquez-Otero I; Medina-Cintrón N; Arroyo-Ávila M; González-Sepúlveda L; Vilá LM
Lupus Sci Med; 2020 May; 7(1):. PubMed ID: 32434863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]